Next Science Ltd (AU:NXS) recently announced a significant update regarding its sales force structure. The company has implemented changes to reduce costs and enhance operational efficiency, with anticipated annual savings of approximately US$6 million. These changes come as Next Science reports a rise in product sales and a strong gross margin, indicating a positive outlook for the future.
The company is confident in its ability to meet its FY24 revenue guidance of US$36m-$40m, while also aiming to achieve EBITDA and positive cashflow in the second half of the fiscal year. This strategic shift includes moving towards a more flexible, commission-based sales team and leveraging new market opportunities to drive further growth.
Investors interested in AU:NXS stock can find more information on TipRanks’ Stock Analysis page.
At the forefront of brain research are Harvard and Google, working together to unlock the…
The Prime Minister of Slovakia, Robert Fico, was reported to have been stabilized in recent…
Mild food poisoning can be treated at home using herbs such as green beans, star…
A local nurse practitioner in DC is revolutionizing medical care in underserved communities by opening…
Each person secretes different pheromones that can attract mosquitoes, along with factors such as body…
Jan Leike believes that OpenAI has taken on a significant responsibility on behalf of all…